News | March 16, 2026
C2N Diagnostics expands Alzheimer’s blood test to South Korea via BeauBrain partnership
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
Emcure to distribute Roche's kidney transplant and anemia drugs in India
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
To support this launch, ImmunityBio has established a wholly owned subsidiary in Saudi Arabia
DeslaFlex is an innovative antidepressant formulation developed by Spektus using the proprietary Flexitab oral drug-delivery platform
The partnership initially will focus on cardiovascular and kidney diseases
The collaboration will focus on enhancing surgeon capabilities, developing structured training pathways, and promoting the adoption of robotic-assisted surgery in both routine and complex procedures
Subscribe To Our Newsletter & Stay Updated
